New 2010 anti-doping list
The World Anti-doping Agency, WADA, has released the updated “2010 Prohibited List” for prohibited substances and methods. This marks WADA's 10th year in existence, a time that has seen efforts to remove drugs in sport grow markedly.
The prohibited substance list is continually being revised and updated as new information becomes available on performance enhancing drugs and the 2010 list reflects this. There is a comprehensive list available on the WADA website at: www.wada-ama.org
Some of the main changes in the 2010 list are:
• The stimulant pseudoephedrine has been reintroduced to the 2010 list. And WADA states, "Given the wide availability of pseudoephedrine-containing medicines, WADA recommends that the reintroduction of pseudoephedrine is supported by active information/education campaign by all stakeholders."
• Supplemental oxygen is no longer a prohibited method.
• The International Nonproprietary Name (INN) for the anabolic agent methyltrienolone has been included (metribolone).
• Growth factors have been addressed in more detail with the addition of examples of growth factors affecting muscle, tendon or ligament protein synthesis/degradation, vascularisation, energy utilisation, regenerative capacity or fibre type switching.
• Two beta-2 agonists, salbutamol and salmeterol can be used by inhalation without needing a Therapeutic Use Exemption, TUE, but usage will need to be declared on the doping control form at the time of a test.
• The maximum dose for the controlled pharmacokinetic study cannot exceed the maximum therapeutic does for inhaled salbutamol.
• Two hormone antagonists have been added: androstene- 3, 6, 17 trione (6-oxo) and androsta-1,4,6-triene-3,17-dione (androstatrienedione). This is in view of their wide availability as components of nutritional supplements.
• Glycerol as a masking agent (a plasma expander) is now included.
• Proteases have been added as a form of manipulation (sample adulteration).
• The status of intravenous infusions has been reviewed and is prohibited except for those legitimately received "in the course of hospital admissions or clinical investigations."
• Three stimulants; benfluorex, prenylamine and methylhexaneamine have been added to the closed list of non-specified stimulants.